News | August 03, 2025
Johnson & Johnson submits additional data to FDA on psoriatic arthritis
The submission is supported by results from the Phase 3b APEX study
The submission is supported by results from the Phase 3b APEX study
The request stemmed from a 2024 lawsuit by Rampart alleging Egg Medical had infringed its patent
Kushwaha previously served as Chief Digital & Information Officer at Jubilant Ingrevia Limited
This case report is jointly authored by US clinicians from leading hospitals, Houston Methodist Hospital, Weill Cornell Medical College and Johns Hopkins
Carbamazepine Extended-Release Tablets are indicated for use as an anticonvulsant drug
Plant-based chemistries have an outsized role to play for the HPC sector by meeting demand for good, gentle, and green products
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
Celecoxib is a nonsteroidal anti-inflammatory drug
In collaboration with the Gates Foundation, Merck advances MK-8527 pre-exposure prophylaxis (PrEP) clinical trials globally
Friesland Campina Professional’s innovative Kievit portfolio features fat powders, creamers, foamers, whipping agents, cake emulsifiers
Subscribe To Our Newsletter & Stay Updated
